ASSESSMENT OF DIFFERENTIAL TREATMENT EFFECT BETWEEN PREDICTED ENDOTYPE SUBGROUPS OF KNEE OSTEOARTHRITIS IN THE MIV-711, UBX0101, AND ORAL SALMON CALCITONIN TRIALS